The burden of hepatitis E among patients with haematological malignancies: a retrospective European cohort study

Background & Aims - The burden of hepatitis E virus (HEV) infection among patients with haematological malignancy has only been scarcely reported. Therefore, we aimed to describe this burden in patients with haematological malignancies, including those receiving allogeneic haematopoietic stem ce...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Felden, Johann von (VerfasserIn) , Alric, Laurent (VerfasserIn) , Pischke, Sven (VerfasserIn) , Aitken, Celia (VerfasserIn) , Schlabe, Stefan (VerfasserIn) , Spengler, Ulrich (VerfasserIn) , Giordani, Maria Teresa (VerfasserIn) , Schnitzler, Paul (VerfasserIn) , Bettinger, Dominik (VerfasserIn) , Thimme, Robert (VerfasserIn) , Xhaard, Alienor (VerfasserIn) , Binder, Mascha (VerfasserIn) , Ayuk, Francis (VerfasserIn) , Lohse, Ansgar W. (VerfasserIn) , Cornelissen, Jan J. (VerfasserIn) , de Man, Robert A. (VerfasserIn) , Mallet, Vincent (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 18 May 2019
In: Journal of hepatology
Year: 2019, Jahrgang: 71, Heft: 3, Pages: 465-472
ISSN:1600-0641
DOI:10.1016/j.jhep.2019.04.022
Online-Zugang:Verlag, Volltext: https://doi.org/10.1016/j.jhep.2019.04.022
Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S0168827819302909
Volltext
Verfasserangaben:Johann von Felden, Laurent Alric, Sven Pischke, Celia Aitken, Stefan Schlabe, Ulrich Spengler, Maria Teresa Giordani, Paul Schnitzler, Dominik Bettinger, Robert Thimme, Alienor Xhaard, Mascha Binder, Francis Ayuk, Ansgar W. Lohse, Jan J. Cornelissen, Robert A. de Man, Vincent Mallet

MARC

LEADER 00000caa a2200000 c 4500
001 168199576X
003 DE-627
005 20230428191326.0
007 cr uuu---uuuuu
008 191116s2019 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.jhep.2019.04.022  |2 doi 
035 |a (DE-627)168199576X 
035 |a (DE-599)KXP168199576X 
035 |a (OCoLC)1341251173 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Felden, Johann von  |d 1985-  |e VerfasserIn  |0 (DE-588)1044673249  |0 (DE-627)772417237  |0 (DE-576)398034818  |4 aut 
245 1 4 |a The burden of hepatitis E among patients with haematological malignancies  |b a retrospective European cohort study  |c Johann von Felden, Laurent Alric, Sven Pischke, Celia Aitken, Stefan Schlabe, Ulrich Spengler, Maria Teresa Giordani, Paul Schnitzler, Dominik Bettinger, Robert Thimme, Alienor Xhaard, Mascha Binder, Francis Ayuk, Ansgar W. Lohse, Jan J. Cornelissen, Robert A. de Man, Vincent Mallet 
264 1 |c 18 May 2019 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 16.11.2019 
520 |a Background & Aims - The burden of hepatitis E virus (HEV) infection among patients with haematological malignancy has only been scarcely reported. Therefore, we aimed to describe this burden in patients with haematological malignancies, including those receiving allogeneic haematopoietic stem cell transplantation. - Methods - We conducted a retrospective, multicentre cohort study across 11 European centres and collected clinical characteristics of 50 patients with haematological malignancy and RNA-positive, clinically overt hepatitis E between April 2014 and March 2017. The primary endpoint was HEV-associated mortality; the secondary endpoint was HEV-associated liver-related morbidity. - Results - The most frequent underlying haematological malignancies were aggressive non-Hodgkin lymphoma (NHL) (34%), indolent NHL (iNHL) (24%), and acute leukaemia (36%). Twenty-one (42%) patients had received allogeneic haematopoietic stem cell transplantation (alloHSCT). Death with ongoing hepatitis E occurred in 8 (16%) patients, including 1 patient with iNHL and 1 patient >100days after alloHSCT in complete remission, and was associated with male sex (p=0.040), cirrhosis (p=0.006) and alloHSCT (p=0.056). Blood-borne transmission of hepatitis E was demonstrated in 5 (10%) patients, and associated with liver-related mortality in 2 patients. Hepatitis E progressed to chronic hepatitis in 17 (34%) patients overall, and in 10 (47.6%) and 6 (50%) alloHSCT and iNHL patients, respectively. Hepatitis E was associated with acute or acute-on-chronic liver failure in 4 (8%) patients with 75% mortality. Ribavirin was administered to 24 (48%) patients, with an HEV clearance rate of 79.2%. Ribavirin treatment was associated with lower mortality (p=0.037) and by trend with lower rates of chronicity (p=0.407) when initiated <24 and <12weeks after diagnosis of hepatitis E, respectively. Immunosuppressive treatment reductions were associated with mortality in 2 patients (28.6%). - Conclusion - Hepatitis E is associated with mortality and liver-related morbidity in patients with haematological malignancy. Blood-borne transmission contributes to the burden. Ribavirin should be initiated early, whereas reduction of immunosuppressive treatment requires caution. - Lay summary - Little is known about the burden of hepatitis E among patients with haematological malignancy. We conducted a retrospective European cohort study among 50 patients with haematological malignancy, including haematopoietic stem cell transplant recipients, with clinically significant HEV infection and found that hepatitis E is associated with hepatic and extrahepatic mortality, including among patients with indolent disease or among stem cell transplant recipients in complete remission. Hepatitis E virus infection evolved to chronic hepatitis in 5 (45.5%) patients exposed to a rituximab-containing regimen and 10 (47.6%) stem cell transplant recipients. Reducing immunosuppressive therapy because of hepatitis E was associated with mortality, while early ribavirin treatment was safe and effective. 
650 4 |a Blood transfusion 
650 4 |a Haematopoietic stem cell transplantation 
650 4 |a Hepatitis E virus 
650 4 |a Immunocompromised host 
650 4 |a Outcome 
650 4 |a Ribavirin 
700 1 |a Alric, Laurent  |e VerfasserIn  |4 aut 
700 1 |a Pischke, Sven  |e VerfasserIn  |4 aut 
700 1 |a Aitken, Celia  |e VerfasserIn  |4 aut 
700 1 |a Schlabe, Stefan  |e VerfasserIn  |4 aut 
700 1 |a Spengler, Ulrich  |e VerfasserIn  |4 aut 
700 1 |a Giordani, Maria Teresa  |e VerfasserIn  |4 aut 
700 1 |a Schnitzler, Paul  |d 1959-  |e VerfasserIn  |0 (DE-588)1022905643  |0 (DE-627)717329798  |0 (DE-576)366155695  |4 aut 
700 1 |a Bettinger, Dominik  |e VerfasserIn  |4 aut 
700 1 |a Thimme, Robert  |e VerfasserIn  |4 aut 
700 1 |a Xhaard, Alienor  |e VerfasserIn  |4 aut 
700 1 |a Binder, Mascha  |e VerfasserIn  |4 aut 
700 1 |a Ayuk, Francis  |e VerfasserIn  |4 aut 
700 1 |a Lohse, Ansgar W.  |e VerfasserIn  |4 aut 
700 1 |a Cornelissen, Jan J.  |e VerfasserIn  |4 aut 
700 1 |a de Man, Robert A.  |e VerfasserIn  |4 aut 
700 1 |a Mallet, Vincent  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Journal of hepatology  |d Amsterdam [u.a.] : Elsevier Science, 1985  |g 71(2019), 3, Seite 465-472  |h Online-Ressource  |w (DE-627)320984486  |w (DE-600)2027112-8  |w (DE-576)093888856  |x 1600-0641  |7 nnas  |a The burden of hepatitis E among patients with haematological malignancies a retrospective European cohort study 
773 1 8 |g volume:71  |g year:2019  |g number:3  |g pages:465-472  |g extent:8  |a The burden of hepatitis E among patients with haematological malignancies a retrospective European cohort study 
856 4 0 |u https://doi.org/10.1016/j.jhep.2019.04.022  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u http://www.sciencedirect.com/science/article/pii/S0168827819302909  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20191116 
993 |a Article 
994 |a 2019 
998 |g 1022905643  |a Schnitzler, Paul  |m 1022905643:Schnitzler, Paul  |d 910000  |d 911700  |e 910000PS1022905643  |e 911700PS1022905643  |k 0/910000/  |k 1/910000/911700/  |p 8 
999 |a KXP-PPN168199576X  |e 3541060182 
BIB |a Y 
SER |a journal 
JSO |a {"origin":[{"dateIssuedDisp":"18 May 2019","dateIssuedKey":"2019"}],"note":["Gesehen am 16.11.2019"],"relHost":[{"type":{"bibl":"periodical","media":"Online-Ressource"},"part":{"year":"2019","pages":"465-472","text":"71(2019), 3, Seite 465-472","volume":"71","extent":"8","issue":"3"},"title":[{"title":"Journal of hepatology","subtitle":"official journal of the European Association for the Study of the Liver","title_sort":"Journal of hepatology"}],"disp":"The burden of hepatitis E among patients with haematological malignancies a retrospective European cohort studyJournal of hepatology","physDesc":[{"extent":"Online-Ressource"}],"language":["eng"],"id":{"eki":["320984486"],"zdb":["2027112-8"],"issn":["1600-0641"]},"origin":[{"publisherPlace":"Amsterdam [u.a.] ; [Erscheinungsort nicht ermittelbar]","publisher":"Elsevier Science ; Wiley-Blackwell","dateIssuedDisp":"1985-","dateIssuedKey":"1985"}],"note":["Gesehen am 18.02.2020"],"pubHistory":["1.1985 -"],"recId":"320984486"}],"recId":"168199576X","type":{"bibl":"article-journal","media":"Online-Ressource"},"name":{"displayForm":["Johann von Felden, Laurent Alric, Sven Pischke, Celia Aitken, Stefan Schlabe, Ulrich Spengler, Maria Teresa Giordani, Paul Schnitzler, Dominik Bettinger, Robert Thimme, Alienor Xhaard, Mascha Binder, Francis Ayuk, Ansgar W. Lohse, Jan J. Cornelissen, Robert A. de Man, Vincent Mallet"]},"language":["eng"],"id":{"doi":["10.1016/j.jhep.2019.04.022"],"eki":["168199576X"]},"physDesc":[{"extent":"8 S."}],"person":[{"display":"Felden, Johann von","given":"Johann von","role":"aut","family":"Felden"},{"role":"aut","display":"Alric, Laurent","given":"Laurent","family":"Alric"},{"family":"Pischke","display":"Pischke, Sven","given":"Sven","role":"aut"},{"family":"Aitken","given":"Celia","display":"Aitken, Celia","role":"aut"},{"family":"Schlabe","given":"Stefan","display":"Schlabe, Stefan","role":"aut"},{"display":"Spengler, Ulrich","given":"Ulrich","role":"aut","family":"Spengler"},{"family":"Giordani","role":"aut","display":"Giordani, Maria Teresa","given":"Maria Teresa"},{"family":"Schnitzler","role":"aut","given":"Paul","display":"Schnitzler, Paul"},{"display":"Bettinger, Dominik","given":"Dominik","role":"aut","family":"Bettinger"},{"role":"aut","given":"Robert","display":"Thimme, Robert","family":"Thimme"},{"given":"Alienor","display":"Xhaard, Alienor","role":"aut","family":"Xhaard"},{"role":"aut","given":"Mascha","display":"Binder, Mascha","family":"Binder"},{"family":"Ayuk","role":"aut","display":"Ayuk, Francis","given":"Francis"},{"role":"aut","display":"Lohse, Ansgar W.","given":"Ansgar W.","family":"Lohse"},{"family":"Cornelissen","role":"aut","display":"Cornelissen, Jan J.","given":"Jan J."},{"family":"de Man","role":"aut","given":"Robert A.","display":"de Man, Robert A."},{"given":"Vincent","display":"Mallet, Vincent","role":"aut","family":"Mallet"}],"title":[{"title_sort":"burden of hepatitis E among patients with haematological malignancies","subtitle":"a retrospective European cohort study","title":"The burden of hepatitis E among patients with haematological malignancies"}]} 
SRT |a FELDENJOHABURDENOFHE1820